dr. roy herbst | yale cancer center | asco 2020 osimertinib/adaura trial results
Published 4 years ago • 467 plays • Length 1:49
Download video MP4
Download video MP3
Similar videos
-
3:14
dr. roy herbst, yale cancer center/smilow cancer hospital
-
1:12
dr. roy herbst on the emergence of immunotherapy in cancer
-
1:27
medical fellow thank you/dr. roy herbst
-
2:25
roy herbst, md, phd, discusses next steps in clinical development of osimertinib in adjuvant nsclc
-
2:30
roy herbst, md, phd, shares perspective on the plenary session presentation of the adaura study
-
1:31
roy herbst, md, phd, explains the 3-year length of adjuvant treatment strategy in adaura
-
1:18
dr. herbst on next-generation agents in nsclc
-
7:11
roy herbst, md, phd, acceptance speech/ 2020 aacr distinguished public service award
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
2:54
aacr fellows explain what they find exciting in cancer research today
-
1:15:06
science distilled: advances in cancer research
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
1:01:28
translational lung cancer research at yale: 10 years-in-review
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
2:15
dr. herbst on the next generation of lung cancer trials
-
1:03
dr. herbst on combination therapies for lung cancer
-
3:06
roy s. herbst, md, phd, elaborates on the design and outcomes of the empower-lung 1 clinical study
-
4:56
researcher comment: the adaura trial | roy herbst
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
1:23
dr. roy s. herbst explores molecular testing in lung cancer
-
11:58
asco 2023 - astrazeneca - positive results from adaura phase iii trial
Clip.africa.com - Privacy-policy